ICU Medical, Inc. ICUI
164.95
(1.07)
(0.64%)
as of 25 Sep
- Market cap
- $4.2B
- P/E
- 137×
Follow ICUI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 1.41% | 2.26% | 0.04% | (0.35%) |
+8 more TTM periods Free account |
|
| 0.74% | 1.13% | 0.02% | (0.18%) | ||
ROIC |
1.46% | 0.88% | 0.86% | 1.49% | |
Return on Tangible Assets |
2.60% | 4.06% | 0.06% | (0.63%) | |
Average Days of Receivables |
31.02 | 34.03 | 29.53 | 30.13 | |
Free Cash Flow per Share |
6.12 | 3.31 | 3.69 | 2.52 | |
Free Cash Flow |
152.88 | 82.08 | 90.89 | 62.33 | |
Capital Expenditures |
(83.49) | (85.35) | (88.96) | (97.11) | |
Piotroski F-Score |
6.00 | 6.00 | 6.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
6.42% | 4.55% | 4.84% | 4.26% | |
Accounts Receivable Turnover |
11.90 | 11.60 | 12.28 | 12.70 | |
Accounts Payable Turnover |
8.27 | 7.55 | 9.32 | 8.66 | |
Inventory Turnover |
2.15 | 2.24 | 2.35 | 2.24 | |
Average Days of Payables |
41.42 | 47.44 | 39.98 | 42.53 | |
Days of Inventory on Hand |
168.67 | 165.12 | 159.51 | 154.13 | |
Tax Rate |
41.05 | 3.26 | (0.56) | (1.30) | |
Research and Development Expense of Revenue |
4.00% | 3.96% | 3.92% | 3.83% | |
Selling, General and Administrative Expense of Revenue |
28.48% | 28.86% | 28.02% | 27.08% | |
Share Based Compensation of Revenue |
2.55% | 2.67% | 2.50% | 2.34% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
7.86 | 3.61 | 245.69 | (21.66) | |
Depreciation/Fixed assets |
0.46 | 0.46 | 0.46 | 0.46 | |
Capex/Depreciation |
(0.41) | (0.41) | (0.43) | (0.46) | |
Revenue per Share |
86.38 | 87.09 | 90.55 | 94.00 | |
Operating CF per Share |
9.45 | 6.76 | 7.30 | 6.46 | |
Capex per Share |
(3.34) | (3.45) | (3.61) | (3.93) | |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.04 | |
Net Profit Margin |
1.39% | 2.15% | 0.03% | (0.32%) |
Columns are period end dates